Page last updated: 2024-08-21

erythromycin and acebutolol

erythromycin has been researched along with acebutolol in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19907 (31.82)18.7374
1990's0 (0.00)18.2507
2000's8 (36.36)29.6817
2010's7 (31.82)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Abraham, MH; Acree, WE; Ibrahim, A1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, X; Lin, X; Skolnik, S; Wang, J1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Greener, A; Khan, NA1
Ichikawa, Y; Udou, T1
Fensom, AH; Kurowski, WM; Pirt, SJ1
McKay, LL; Polzin, KM; Steele, JL1
Ogra, MS1
Bovre, K; Henriksen, SD1
LATTIMER, JK; PEER, P; SENECA, H1

Reviews

1 review(s) available for erythromycin and acebutolol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

21 other study(ies) available for erythromycin and acebutolol

ArticleYear
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Effect of the petite mutation on maltose and alpha-methylgucoside fermentation inSaccharomyces cerevisiae.
    Molecular & general genetics : MGG, 1977, Jan-07, Volume: 150, Issue:1

    Topics: Erythromycin; Fermentation; Genes; Maltose; Methylglucosides; Methylglycosides; Mutation; Saccharomyces cerevisiae

1977
Characteristics of extracellular nuclease production in Staphylococcus aureus.
    Microbiology and immunology, 1979, Volume: 23, Issue:7

    Topics: Cycloserine; Dactinomycin; Erythromycin; Glucose; Macromolecular Substances; Maltose; Micrococcal Nuclease; Nalidixic Acid; Staphylococcus aureus

1979
Factors influencing the formation and stability of D-glucoside 3-dehydrogenase activity in cultures of Agrobacterium tumefaciens.
    Journal of general microbiology, 1975, Volume: 90, Issue:2

    Topics: Alcohol Oxidoreductases; Chloramphenicol; Dinitrophenols; Enzyme Repression; Erythromycin; Glycosides; Hydroxyquinolines; Kinetics; Maltose; Manganese; Methylglucosides; Nitrogen; Phosphates; Rhizobium; Succinates; Sucrose

1975
Characterization of the genetic element coding for lactose metabolism in Lactococcus lactis subsp. lactis KP3.
    Plasmid, 1989, Volume: 22, Issue:1

    Topics: Bacteriophages; Conjugation, Genetic; Deoxyribonuclease EcoRI; Erythromycin; Genes, Bacterial; Lactococcus lactis; Lactose; Lactose Factors; Maltose; Mutation; Nucleic Acid Hybridization; Phenotype; Plasmids; Recombination, Genetic; Rifampin; Streptomycin; Transformation, Bacterial

1989
Isolation and characterization of Mycoplasma meleagridis.
    Canadian journal of microbiology, 1972, Volume: 18, Issue:2

    Topics: Animals; Antibodies; Arginine; Chickens; Culture Media; Erythromycin; Female; Glucose; Hemagglutination Tests; Male; Maltose; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Oleandomycin; Poultry Diseases; Sucrose; Tetrazolium Salts; Turkeys; Vagina

1972
Moraxella kingii sp.nov., a haemolytic, saccharolytic species of the genus Moraxella.
    Journal of general microbiology, 1968, Volume: 51, Issue:3

    Topics: Catalase; Chloramphenicol; DNA, Bacterial; Erythromycin; Glucose; Hemolysis; Maltose; Moraxella; Oxytetracycline; Penicillin Resistance; Penicillins; Streptomycin; Transformation, Genetic

1968
ATTEMPTS TO GROW DRUG-RESISTANT CULTURES OF LACTOBACILLI FOR THE PRODUCTION OF YOGURT.
    Journal of the American Geriatrics Society, 1963, Volume: 11

    Topics: Anti-Bacterial Agents; Chloramphenicol; Dairy Products; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Glucose; Isocitrate Dehydrogenase; Lactobacillus; Maltose; Mannitol; Nitrofurantoin; Novobiocin; Oxidoreductases; Penicillins; Peptones; Potassium; Saccharomyces; Streptococcus; Streptomycin; Sulfonamides; Tetracycline; Urease; Water; Yogurt

1963